MedTrace Logo

The ROVO Study: Radial Optic Neurotomy for CVO

NCT00532142 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL

Last updated 2009-10-30

No results posted yet for this study

Summary

The ROVO study is a prospective, placebocontrolled and randomised study designed to evaluate the effect of radial optic neurotomy in central vein occlusion, versus triamcinolone acetonide. 240 patients with a visual acuity \< 0.5 Snellen will be randomised. Patients are treated with either RON, or a single intravitreal injection of 4 mg triamcinolone acetonide, or a placebo treatment - a "sham" injection of intravitreal triamcinolone. Patients will be examined regularly over a period of one year.

Best corrected visual acuity for far and near, as well as clinical examinations, fluorescein- and indocyanine green angiograms, optical coherence tomography, and perimetry, are performed pre- and postoperatively.

Conditions

  • Central Retinal Vein Occlusion

Interventions

DRUG

Intravitreal Triamcinolone

PROCEDURE

Radial Optic Neurotomy

OTHER

Placebo - Sham Intravitreal Injection

Sponsors & Collaborators

  • Rudolf Foundation Clinic

    lead OTHER

Principal Investigators

  • Susanne Binder, M.D. · no affiliation

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-04-30
Completion
2009-08-31

Countries

  • Austria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00532142 on ClinicalTrials.gov